Manoussos Perros

Chief Executive Officer, Entasis Therapeutics.

Companies

Entasis TherapeuticsBoard member Sep 25, 2018 to Jul 11, 2022¹
Entasis TherapeuticsChief executive officer Sep 25, 2018 to Jul 11, 2022¹
Entasis TherapeuticsPresident Sep 25, 2018 to Jul 11, 2022¹
Entasis TherapeuticsOfficer Oct 20, 2021 to Jan 19, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Entasis Therapeutics0 shares³Jul 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 11, 2022Returned to company 478,500 shares of Entasis Therapeutics³
Jul 7, 2022U 56,072 shares at $2.20 of Entasis Therapeutics³
Jan 18, 2022Granted 125,000 shares of Entasis Therapeutics⁴
Nov 2, 2021Shares withheld for tax 11,704 shares at $2.94 of Entasis Therapeutics⁵
Oct 19, 2021Sold 11,974 shares at $3.19 of Entasis Therapeutics⁶
Oct 19, 2021Granted 79,750 shares of Entasis Therapeutics⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREntasis Therapeutics, Board member
2
SEC EDGAREntasis Therapeutics, Officer
3
SEC EDGAREntasis Therapeutics shares after the filing of Jul 11, 2022
4
SEC EDGARForm 4 filed Jan 19, 2022
5
SEC EDGARForm 4 filed Nov 3, 2021
6
SEC EDGARForm 4 filed Oct 20, 2021